https://www.selleckchem.com/pr....oducts/crenolanib-cp
Mean TIR achieved with manual mode was 77.3±11.3, increasing to 81.6%±7.6 (p0.001) after two weeks of auto mode use. A significant reduction in TBR 70mg/dL (2,7%±2,28 vs 1,83%±1,67, p0,001) and in glycemic variability (% coefficient of variation 32.4 vs 29.7, p0.001) was evident, independently of baseline therapy. HCL systems allows T1D patients to improve TIR, TBR and glycemic variability independently of previous treatment. Virtual training can be used during situations that limit the access of patients to
Like
Comment
Share
